Home » Stocks » Biostage

Biostage, Inc. (BSTG)

Stock Price: $2.70 USD 0.20 (8.00%)
Updated Aug 7, 2020 4:00 PM EDT - End of day

Stock Price Chart

Key Info

Market Cap 23.44M
Revenue (ttm) n/a
Net Income (ttm) -8.40M
Shares Out 8.68M
EPS (ttm) -1.13
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 7, 2020
Last Price $2.70
Previous Close $2.50
Change ($) 0.20
Change (%) 8.00%
Day's Open 2.90
Day's Range 2.70 - 2.90
Day's Volume 395
52-Week Range 1.79 - 4.88

More Stats

Market Cap 23.44M
Enterprise Value 22.75M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 8.68M
Float 4.23M
EPS (basic) -1.13
EPS (diluted) -1.13
FCF / Share -0.73
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 121,658
Short Ratio 3.35
Short % of Float 6.77%
Beta -0.14
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 33.70
Revenue n/a
Operating Income -8.73M
Net Income -8.40M
Free Cash Flow -6.04M
Net Cash 690,000
Net Cash / Share 0.08
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -269.44%
ROE -848.16%
ROIC -3,146.40%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$60.00*
Low
60.0
Current: $2.70
High
60.0
Target: 60.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue---0.080.120.090.02---
Revenue Growth----30.51%26.88%322.73%----
Gross Profit----0.03-0.020.050.01---
Operating Income-8.87-7.84-11.47-12.13-11.70-11.06-8.82-6.71-3.75-1.35
Net Income-8.33-7.53-11.92-11.58-11.70-11.06-8.82-6.71-3.75-1.35
Shares Outstanding6.904.461.800.800.560.390.390.39--
Earnings Per Share-1.21-1.69-6.63-14.49-21.00-28.20-22.80-17.40--
Operating Cash Flow-6.06-7.64-11.01-9.06-7.19-7.99-7.69-5.90-3.57-1.05
Capital Expenditures-0.13-0.07-0.14-0.30-0.18-1.16-0.30-0.31-0.21-
Free Cash Flow-6.19-7.71-11.15-9.36-7.36-9.16-7.98-6.21-3.78-1.05
Cash & Equivalents0.961.364.042.947.465.2714.010.000.000.00
Total Debt0.19---------
Net Cash / Debt0.771.364.042.947.465.2714.010.000.000.00
Assets1.992.635.054.558.967.2015.060.440.19-
Liabilities0.900.661.622.780.650.710.500.410.17-
Book Value1.091.973.421.778.306.4914.570.030.02-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Biostage, Inc.
Country United States
Employees 9

Stock Information

Ticker Symbol BSTG
Stock Exchange US OTC
Sector Healthcare
Industry Biotechnology
Unique Identifier OTCMKTS: BSTG

Description

Biostage, Inc., a biotechnology company, engages in developing bioengineered organ implants based on its Cellframe technology. The company's Cellframe technology comprises a biocompatible scaffold that is seeded with the recipient's own stem cells. It is developing its Cellframe technology to treat life-threatening conditions of the esophagus, bronchus, or trachea. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2007 and is headquartered in Holliston, Massachusetts.